Indian Cabazitaxel Exporters: Complete Supplier Ranking with Market Share — 59 Manufacturers (2026) — TransData Nexus

Q: Who is the largest cabazitaxel supplier from India?

INTAS PHARMACEUTICALS LIMITED is the largest cabazitaxel exporter from India with a 38.4% market share and export value of $3.5M.

Q: How many cabazitaxel suppliers are there in India?

There are 59 active cabazitaxel exporters in India, collectively shipping $9.2M worth of cabazitaxel across 307 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top cabazitaxel suppliers from India?

The top 5 cabazitaxel suppliers from India — INTAS PHARMACEUTICALS LIMITED, MSN LABORATORIES PRIVATE LIMITED, DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED, INTAS PHARMACEUTICALS LTD — together control 69.7% of total cabazitaxel export value from India.

Suresh Sormare

Cabazitaxel

India Pharmaceutical Trade Intelligence

$9.2M59 Suppliers49 CountriesHS 30049049

ExportsIndia → RUSSIA25.7%India → ITALY14.8%

ImportsCANADA → India$304.7K UNITED STATES → India$105.3K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: ACCORD HEALTHCARE

Cabazitaxel Suppliers from India (2026) — 59 Exporters, $9.2M Market | TransData Nexus | TransData Nexus

Who Exports Cabazitaxel from India — 59 Suppliers Behind a $9.2M Market

India's cabazitaxel export market is supplied by 59 active exporters who collectively shipped $9.2M across 307 shipments. INTAS PHARMACEUTICALS LIMITED leads with a 38.4% market share, followed by MSN LABORATORIES PRIVATE LIMITED and DR REDDY S LABORATORIES LIMITED. The top 5 suppliers together control 69.7% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Cabazitaxel Suppliers & Exporters — 59 manufacturers, $9.2M export market, top destinations and formulations — Cabazitaxel supplier data — 59 exporters · $9.2M market · 307 shipmentsTransData Nexus · Indian Customs Data

Top Cabazitaxel Exporters from India — Ranked by Export Value

INTAS PHARMACEUTICALS LIMITED is the leading cabazitaxel exporter from India, holding a 38.4% share of the $9.2M market across 307 shipments from 59 exporters. The top 5 suppliers — INTAS PHARMACEUTICALS LIMITED, MSN LABORATORIES PRIVATE LIMITED, DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED, INTAS PHARMACEUTICALS LTD — collectively control 69.7% of total export value, indicating a moderately concentrated market. Individual shares are: INTAS PHARMACEUTICALS LIMITED (38.4%), MSN LABORATORIES PRIVATE LIMITED (17.0%), DR REDDY S LABORATORIES LIMITED (5.7%), DR REDDYS LABORATORIES LIMITED (5.7%), INTAS PHARMACEUTICALS LTD (3.0%).

Top Cabazitaxel Exporters from India

Ranked by export value · 59 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Cabazitaxel Exporters from India — Ranked by Export Value. 59 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Cabazitaxel exporters

Certification and compliance status for top Cabazitaxel suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Intas Pharmaceuticals Limited	Warning Letter, July 2023	Yes, April 2007	Yes	Not verified	Received FDA warning letters in July and November 2023 for CGMP violations; WHO-
Dr. Reddy's Laboratories Limited	Approved	Yes	Yes	89	Holds FDA approvals and WHO-GMP certification; has 89 approved ANDAs.

TransData Nexus reviewed the regulatory standing of 2 leading Cabazitaxel exporters from India. 1 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 2 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Cabazitaxel sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts numerous pharmaceutical companies specializing in active pharmaceutical ingredients (APIs) and bulk drugs. Notable firms include A.R. Life Sciences, which manufactures a wide range of APIs for treatments such as cardiovascular diseases and leukemia. Additionally, Hyderabad's Pharma City project has been recognized as a National Investment Manufacturing Zone, further solidifying its status as a pharmaceutical hub.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations and contract manufacturing capabilities. Vadodara, in particular, is home to companies like Wellmed Pharma, which offers a comprehensive range of pharmaceutical products, including tablets, ointments, and injectables. The region's focus on formulations makes it a strategic location for sourcing finished pharmaceutical products.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to global markets. Companies like Formel Labs have manufacturing facilities in Mumbai, emphasizing the region's role in pharmaceutical production and export. The proximity to international shipping routes enhances the efficiency of exporting pharmaceuticals from this cluster.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Cabazitaxel exporters from India

March 2025

Divestiture

Dr. Reddy's Laboratories Limited — Senores Pharma acquires 14 ANDAs from Dr. Reddy's

Dr. Reddy's Laboratories divested a portfolio of 14 Abbreviated New Drug Applications (ANDAs) to Senores Pharmaceuticals. This portfolio included 13 approved ANDAs and one pending approval. - IMPACT: This divestiture is not expected to directly impact Dr. Reddy's Cabazitaxel exports, as the ANDAs involved pertain to different products.

Impact: This divestiture is not expected to directly impact Dr. Reddy's Cabazitaxel exports, as the ANDAs involved pertain to different products.

February 2022

Acquisition

Dr. Reddy's Laboratories Limited — Dr. Reddy's acquires Nimbus Health GmbH

Dr. Reddy's Laboratories acquired Nimbus Health GmbH, a German pharmaceutical wholesaler specializing in medical cannabis. - IMPACT: This acquisition is unlikely to affect Dr. Reddy's Cabazitaxel exports, as it focuses on expanding the company's presence in the medical cannabis market.

Impact: This acquisition is unlikely to affect Dr. Reddy's Cabazitaxel exports, as it focuses on expanding the company's presence in the medical cannabis market.

Common Questions — Cabazitaxel Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which cabazitaxel supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, INTAS PHARMACEUTICALS LIMITED leads with 108 recorded shipments worth $3.5M. MSN LABORATORIES PRIVATE LIMITED (37 shipments) and DR REDDY S LABORATORIES LIMITED (3 shipments) are also established high-volume exporters.

Q How many cabazitaxel manufacturers are there in India?

India has 59 active cabazitaxel exporters with a combined export market of $9.2M across 307 shipments to 49 countries. The top 5 suppliers hold 69.7% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for cabazitaxel from India?

Average FOB unit price: $123.65 per unit, ranging from $0.08 to $2237.14. Average shipment value: $30.1K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Cabazitaxel

Cabazitaxel

Who Exports Cabazitaxel from India — 59 Suppliers Behind a $9.2M Market

Top Cabazitaxel Exporters from India — Ranked by Export Value

Top Cabazitaxel Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Dr. Reddy's Laboratories Limited — Senores Pharma acquires 14 ANDAs from Dr. Reddy's

Dr. Reddy's Laboratories Limited — Dr. Reddy's acquires Nimbus Health GmbH

Common Questions — Cabazitaxel Suppliers from India

Q Which cabazitaxel supplier from India is the most reliable for bulk orders?

Q How many cabazitaxel manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for cabazitaxel from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Dr. Reddy's Laboratories Limited — Dr. Reddy's acquires India trademarks for two HRT drugs

Analysis Methodology